We have developed a retroviral vector that incorporates unique features of
some previously described vectors. This vector includes: 3' long terminal r
epents (LTRs) of the self-inactivating class; a 5' LTR that is a hybrid of
the cytomegalovirus (CMV) enhancer and the mouse sarcoma virus promoter; nn
internal CMV immediate early region promoter to drive expression of the tr
ansduced gene and the neomycin phosphotransferase selectable marker an expa
nded,multiple cloning site and an internal ribosome entry site. An SV40 ori
was introduced into the vector backbone to promote high copy number replic
ation in packaging cell lines that express the SV40 large T antigen. We dem
onstrate that these retrocil al constructs, designated Q vectors, can be us
ed in applications where high viral titers and high level stable or transie
nt gene expression are desirable.